Medicare enrollees who buy the optional Part D drug benefit may see price hikes of up to $50 a month when they shop for next ...

"The new enforcement areas have to do with drug pricing, in particular rebate payments to get access to formularies," said ...

A federal appeals panel voted 2-to-1 against a group of international aid groups, ruling they did not have the legal standing to bring a lawsuit. Meanwhile, the Trump administration has ordered a ...

As lawyers who represent whistleblowers under the False Claims Act, we expect a new era of fraud cases tied to GLP-1 drugs, ...

Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

An appeals panel found that a pharmaceutical company's participation in Medicare's drug price negotiation program is ...

Health and Human Services Secretary Robert F. Kennedy Jr.'s announcement that the federal government will cancel nearly $500 million in mRNA research funding is unnerving not only for those who ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

In the letters, Trump gave the pharmaceutical firms until Sept. 29 to make a series of commitments that aim to provide “immediate relief from the vastly inflated drug prices and put an end to the free ...